Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by loss of motor neurons. The mechanisms leading to motor neuron degeneration in ALS are unclear. However, there is evidence for involvement of endoplasmic reticulum (ER) stress and the unfolded protein resp...
Main Authors: | Fernando G Vieira, Qinggong Ping, Andy J Moreno, Joshua D Kidd, Kenneth Thompson, Bingbing Jiang, John M Lincecum, Monica Z Wang, Gerard S De Zutter, Valerie R Tassinari, Beth Levine, Theo Hatzipetros, Alan Gill, Steven Perrin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4545826?pdf=render |
Similar Items
-
CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits
by: Fernando G. Vieira, et al.
Published: (2017-06-01) -
PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS
by: Fernando G. Vieira, et al.
Published: (2024-01-01) -
PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS.
by: Fernando G Vieira, et al.
Published: (2024-01-01) -
Guanabenz interferes with ER stress and exerts protective effects in cardiac myocytes.
by: Christiane Neuber, et al.
Published: (2014-01-01) -
Guanabenz inhibits alveolar bone resorption in a rat model of periodontitis
by: Ryujiro Muramatsu, et al.
Published: (2021-11-01)